Monday 16 November 2026
Export KYNB’s income statement to Excel — free account
Kyntra Bio Inc
KYNBKyntra Bio Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.4 million, down 78.3% from fiscal 2024.
- Revenue
- n/m
- EPS
- n/m
- Free cash flow
- n/m
Quarter to June 2026, against a year earlier
3.44
0.15
−4.18%
Follow KYNB
Alert me
Revenue to profit Fiscal 2025, year to 31 December 2025
Of every $100 of revenue, $2848.63 was left as profit. What is an income statement?
| Revenue | 0.0 | 100.0% |
|---|---|---|
| Cost of revenue | 0.0 | −8.6% |
| Gross profit | 0.0 | 91.4% |
| Research & development | 0.0 | −365.2% |
| Selling, general & admin | 0.0 | −430.3% |
| Other operating costs | 0.0 | −8.6% |
| Operating income | 0.0 | −712.7% |
| Other income, net | 0.0 | −192.5% |
| Income tax | 0.0 | 1.4% |
| Other items | +0.2 | 3752.4% |
| Net income | 0.2 | 2848.6% |
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.2B | $0.1B | $0.2B | $0.3B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| Operating income | −$0.1B | −$0.1B | −$0.1B | −$0.1B | −$0.2B | −$0.3B | −$0.3B | −$0.3B | −$0.2B | $0.0B |
| Net income | −$0.1B | −$0.1B | −$0.1B | −$0.1B | −$0.2B | −$0.3B | −$0.3B | −$0.3B | $0.0B | $0.2B |
| Net margin (right axis) | −31.7% | −92.3% | −40.6% | −30.0% | −107.4% | −123.3% | −208.7% | −607.3% | −160.6% | 2848.6% |
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue |
6.44 | 29.62 | 46.80 | 140.73 | 235.31 | 176.32 | 256.58 | 212.96 | 131.00 | 183.19 |
Revenue Growth |
(78.26%) | (36.71%) | (66.74%) | (40.19%) | 33.46% | (31.28%) | 20.48% | 62.57% | (28.49%) | 1.31% |
Cost of Revenue |
0.56 | 15.56 | 3.96 | 20.28 | 12.87 | 8.87 | 1.15 | — | — | — |
Gross Profit |
5.88 | 14.06 | 42.84 | 120.45 | 222.44 | 167.45 | 255.43 | 212.96 | 131.00 | 183.19 |
R&D Expenses |
23.52 | 95.69 | 266.47 | 296.79 | 387.04 | 252.92 | 209.27 | 235.84 | 196.52 | 187.21 |
SG&A Expenses |
27.71 | 49.33 | 86.48 | 124.69 | 123.93 | 106.41 | 135.48 | 63.81 | 51.76 | 46.03 |
Operating Income |
(45.89) | (150.42) | (322.72) | (301.02) | (288.53) | (191.88) | (89.31) | (86.69) | (117.28) | (50.04) |
Non-operating Income/Expense |
(12.40) | (2.95) | (0.50) | 6.16 | (2.15) | 3.15 | 12.67 | 0.58 | (3.27) | (8.10) |
Non-operating Interest Expenses |
8.76 | 8.25 | 8.10 | 1.44 | 1.08 | 2.40 | 2.88 | 10.99 | 9.71 | 10.73 |
Investment Gain/Loss (Other) |
— | — | 2.64 | 1.57 | 1.01 | (0.20) | — | — | — | — |
| (58.29) | (153.37) | (323.22) | (294.87) | (290.68) | (188.73) | (76.64) | (86.12) | (120.55) | (58.14) | |
Income Tax Provision |
(0.09) | (0.27) | (0.25) | 0.36 | 0.35 | 0.36 | 0.33 | 0.30 | 0.32 | (0.07) |
Income after Tax |
(58.20) | (153.10) | (322.97) | (295.23) | (291.03) | (189.09) | (76.97) | (86.42) | (120.87) | (58.07) |
Net Income Common |
183.45 | (47.58) | (284.23) | (293.65) | (290.02) | (189.29) | (76.97) | (86.42) | (120.87) | (58.07) |
EPS (Basic) |
45.37 | (12.00) | (73.00) | (78.50) | (78.50) | (52.75) | (22.25) | (25.75) | (43.25) | (24.50) |
EPS (Diluted) |
45.37 | (12.00) | (73.00) | (78.50) | (78.50) | (52.75) | (22.25) | (25.75) | (43.25) | (24.50) |
Shares (Basic, Weighted) |
4.04 | 4.00 | 3.89 | 3.74 | 3.69 | 3.59 | 3.47 | 3.36 | 2.92 | 2.51 |
Shares (Diluted, Weighted) |
4.04 | 4.00 | 3.89 | 3.74 | 3.69 | 3.59 | 3.47 | 3.36 | 2.92 | 2.51 |
Gross Margin |
91.37% | 47.47% | 91.53% | 85.59% | 94.53% | 94.97% | 99.55% | 100.00% | 100.00% | 100.00% |
EBIT Margin |
(712.66%) | (507.80%) | (689.53%) | (213.90%) | (122.62%) | (108.83%) | (34.81%) | (40.71%) | (89.53%) | (27.32%) |
EBT margin |
(905.19%) | (517.76%) | (690.60%) | (209.52%) | (123.53%) | (107.04%) | (29.87%) | (40.44%) | (92.03%) | (31.74%) |
Net Profit Margin |
2,848.63% | (160.63%) | (607.29%) | (208.66%) | (123.25%) | (107.36%) | (30.00%) | (40.58%) | (92.27%) | (31.70%) |
Free Cash Flow Margin |
(74.72%) | (463.25%) | (678.46%) | (131.22%) | (47.77%) | 44.02% | (32.92%) | (39.44%) | (57.26%) | 3.20% |
EBITDA |
(45.22) | (149.40) | (317.85) | (288.80) | (271.24) | (169.73) | (71.53) | (80.17) | (109.34) | (41.27) |
EBIT |
(45.89) | (150.42) | (322.72) | (301.02) | (288.53) | (191.88) | (89.31) | (86.69) | (117.28) | (50.04) |
Income from Continuous Operations |
(58.20) | (153.10) | (322.97) | (293.65) | (290.02) | (189.29) | (76.97) | (86.42) | (120.87) | (58.07) |
Income from Discontinued Operations |
241.66 | 105.52 | 38.74 | — | — | — | — | — | — | — |
Consolidated Net Income/Loss |
183.45 | (47.58) | (284.23) | (293.65) | (290.02) | (189.29) | (76.97) | (86.42) | (120.87) | (58.07) |
EPS (Basic, from Continuous Ops) |
(14.40) | (38.26) | (83.00) | (78.45) | (78.51) | (52.67) | (22.21) | (25.70) | (41.40) | (23.14) |
EPS (Basic, from Discontinued Ops) |
59.77 | 26.37 | 10.00 | — | — | — | — | — | — | — |
EPS (Basic, Consolidated) |
45.38 | (11.89) | (73.03) | (78.45) | (78.51) | (52.67) | (22.21) | (25.70) | (41.40) | (23.14) |
EPS (Diluted, from Cont. Ops) |
(14.40) | (38.26) | (83.00) | (78.45) | (78.51) | (52.67) | (22.21) | (25.70) | (41.40) | (23.14) |
EPS (Diluted, from Disc. Ops) |
0.00 | 0.00 | 0.00 | — | — | — | — | — | — | — |
Shares (Diluted, Average) |
4.04 | 4.00 | 3.89 | 3.74 | 3.69 | 3.59 | 3.47 | 3.36 | 2.92 | 2.51 |
EPS (Diluted, Consolidated) |
45.38 | (11.89) | (73.03) | (78.45) | (78.51) | (52.67) | (22.21) | (25.70) | (41.40) | (23.14) |
EBITDA Margin |
(702.16%) | (504.39%) | (679.13%) | (205.21%) | (115.27%) | (96.26%) | (27.88%) | (37.65%) | (83.47%) | (22.53%) |
Operating Cash Flow Margin |
(74.13%) | (465.88%) | (673.08%) | (103.69%) | (34.95%) | 46.28% | (30.68%) | (35.76%) | (50.77%) | 3.88% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 25 Oct 2026